Intrinsically disordered proteins access a range of hysteretic phase separation behaviors

The phase separation behavior of intrinsically disordered proteins (IDPs) is thought of as analogous to that of polymers that undergo equilibrium lower or upper critical solution temperature (LCST and UCST, respectively) phase transition. This view, however, ignores possible nonequilibrium propertie...

Full description

Saved in:
Bibliographic Details
Published inScience advances Vol. 5; no. 10; p. eaax5177
Main Authors Garcia Quiroz, Felipe, Li, Nan K, Roberts, Stefan, Weber, Patrick, Dzuricky, Michael, Weitzhandler, Isaac, Yingling, Yaroslava G, Chilkoti, Ashutosh
Format Journal Article
LanguageEnglish
Published United States AAAS 18.10.2019
American Association for the Advancement of Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The phase separation behavior of intrinsically disordered proteins (IDPs) is thought of as analogous to that of polymers that undergo equilibrium lower or upper critical solution temperature (LCST and UCST, respectively) phase transition. This view, however, ignores possible nonequilibrium properties of protein assemblies. Here, by studying IDP polymers (IDPPs) composed of repeat motifs that encode LCST or UCST phase behavior, we discovered that IDPs can access a wide spectrum of nonequilibrium, hysteretic phase behaviors. Experimentally and through simulations, we show that hysteresis in IDPPs is tunable and that it emerges through increasingly stable interchain interactions in the insoluble phase. To explore the utility of hysteretic IDPPs, we engineer self-assembling nanostructures with tunable stability. These findings shine light on the rich phase separation behavior of IDPs and illustrate hysteresis as a design parameter to program nonequilibrium phase behavior in self-assembling materials.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
USDOE Office of Science (SC)
National Science Foundation (NSF)
AC02-05CH11231; R01 GM061232; MIRA R35GM127042; NSF-DMR-1729671
National Institutes of Health (NIH)
Present address: Molecular Foundry, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd, Berkeley, CA 94720, USA.
Present address: Howard Hughes Medical Institute, Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development, The Rockefeller University, New York, New York 10065, USA.
ISSN:2375-2548
2375-2548
DOI:10.1126/sciadv.aax5177